Transcriptomics in T2-High Severe Asthmatics Treated with Biologics: Comparison Between Anti-IgE, Anti-IL-5 and Anti-IL-5R-Targeted Treatments [0.03%]
生物制剂治疗T2高表达重度哮喘的转录组学研究：抗IgE、抗IL-5和抗IL-5R靶向疗法之间的比较
Sara Gerday,Florence Schleich,Mare Sabbe et al.
Sara Gerday et al.
David R Ziehr,Raghu R Chivukula
David R Ziehr
Multi-omic and Single-Cell Approaches for Elucidating Cell Biology and Pathobiology of Lung Disease [0.03%]
多组学和单细胞方法阐明肺部疾病细胞生物学和病理生物学
Aartik Sarma,Xin Sun,Jennifer Sucre et al.
Aartik Sarma et al.
In this Perspective, we review the major themes from a Basic Science Core session at ATS 2024: Multi-omic and single-cell approaches for elucidating cellular biology and pathobiology of lung disease, with a focus on novel biology identified...
Targeting CELA1 to Improve Septation in the Mouse Hyperoxia Model of Impaired Alveolar Development [0.03%]
靶向CELA1可改善新生小鼠缺氧模型肺泡隔的发育缺陷
Noah J Smith,Rashika Joshi,Hitesh Deshmukh et al.
Noah J Smith et al.
Taehyun Kim,Sungmin Moon,Juyeon Lee et al.
Taehyun Kim et al.
When Lipid Mediators Keep Lungs Whole: A Spontaneous, Female-Predominant Model of Emphysema [0.03%]
脂质介质保持肺完整的机制：一种自发的、以女性为主的肺气肿模型
Rene A Girard,Harry Karmouty-Quintana
Rene A Girard
Surfactant Protein (SP)-A Benefits Over SP-A Mutant: A Preliminary Study for ILD Treatment [0.03%]
表面活性物质蛋白(SP)-A治疗间质性肺病(ILD)的初步研究优于SP-A突变体
Tifenn Desroziers,Yohan Soreze,Marie Legendre et al.
Tifenn Desroziers et al.
Surfactant protein (SP)-A, an octadecamer composed of SP-A1 and SP-A2 is secreted into the alveolar space. Heterozygous variations in SFTPA1 and SFTPA2, reported to impair protein secretion, have been associated with interstitial lung disea...
Unraveling the Molecular Complexity of Asthma: Insights from a Multicohort Transcriptome Study [0.03%]
揭秘哮喘的分子复杂性：来自多队列转录组研究的新见解
Heidi Makrinioti,Carlos A Camargo Jr,Zhaozhong Zhu
Heidi Makrinioti